Van Elssen CHMJ - Search Results

1

The Effect of Vitamin C (Ascorbic Acid) in the Treatment of Patients with Cancer: A Systematic Review.

van Gorkom GNY, Lookermans EL, Van Elssen CHMJ, Bos GMJ. van Gorkom GNY, et al. Among authors: van elssen chmj. Nutrients. 2019 Apr 28;11(5):977. doi: 10.3390/nu11050977. Nutrients. 2019. PMID: 31035414 Free PMC article.

2

In vitro-differentiated T/natural killer-cell progenitors derived from human CD34+ cells mature in the thymus.

Meek B, Cloosen S, Borsotti C, Van Elssen CH, Vanderlocht J, Schnijderberg MC, van der Poel MW, Leewis B, Hesselink R, Manz MG, Katsura Y, Kawamoto H, Germeraad WT, Bos GM. Meek B, et al. Blood. 2010 Jan 14;115(2):261-4. doi: 10.1182/blood-2009-05-223990. Epub 2009 Oct 14. Blood. 2010. PMID: 19828700 Free article.

3

Increased tumor-specific CD8+ T cell induction by dendritic cells matured with a clinical grade TLR-agonist in combination with IFN-gamma.

Vanderlocht J, Van Elssen CH, Senden-Gijsbers BL, Meek B, Cloosen S, Libon C, Bos GM, Germeraad WT. Vanderlocht J, et al. Int J Immunopathol Pharmacol. 2010 Jan-Mar;23(1):35-50. doi: 10.1177/039463201002300104. Int J Immunopathol Pharmacol. 2010. PMID: 20377993 Free article.

4

Klebsiella pneumoniae-triggered DC recruit human NK cells in a CCR5-dependent manner leading to increased CCL19-responsiveness and activation of NK cells.

Van Elssen CH, Vanderlocht J, Frings PW, Senden-Gijsbers BL, Schnijderberg MC, van Gelder M, Meek B, Libon C, Ferlazzo G, Germeraad WT, Bos GM. Van Elssen CH, et al. Eur J Immunol. 2010 Nov;40(11):3138-49. doi: 10.1002/eji.201040496. Epub 2010 Sep 24. Eur J Immunol. 2010. PMID: 20865789 Free article.

5

Expression of aberrantly glycosylated Mucin-1 in ovarian cancer.

Van Elssen CH, Frings PW, Bot FJ, Van de Vijver KK, Huls MB, Meek B, Hupperets P, Germeraad WT, Bos GM. Van Elssen CH, et al. Histopathology. 2010 Oct;57(4):597-606. doi: 10.1111/j.1365-2559.2010.03667.x. Histopathology. 2010. PMID: 20955385

6

Flow cytometry-based assay to evaluate human serum MUC1-Tn antibodies.

Van Elssen CH, Clausen H, Germeraad WT, Bennet EP, Menheere PP, Bos GM, Vanderlocht J. Van Elssen CH, et al. J Immunol Methods. 2011 Feb 28;365(1-2):87-94. doi: 10.1016/j.jim.2010.12.006. Epub 2010 Dec 29. J Immunol Methods. 2011. PMID: 21194532 Free article.

7

Elimination of the chemotherapy resistant subpopulation of 4T1 mouse breast cancer by haploidentical NK cells cures the vast majority of mice.

Frings PW, Van Elssen CH, Wieten L, Matos C, Hupperets PS, Schouten HC, Bos GM, van Gelder M. Frings PW, et al. Breast Cancer Res Treat. 2011 Dec;130(3):773-81. doi: 10.1007/s10549-011-1355-z. Epub 2011 Jan 28. Breast Cancer Res Treat. 2011. PMID: 21274621

8

T cells fail to develop in the human skin-cell explants system; an inconvenient truth.

Meek B, Van Elssen CH, Huijskens MJ, van der Stegen SJ, Tonnaer S, Lumeij SB, Vanderlocht J, Kirkland MA, Hesselink R, Germeraad WT, Bos GM. Meek B, et al. BMC Immunol. 2011 Feb 18;12:17. doi: 10.1186/1471-2172-12-17. BMC Immunol. 2011. PMID: 21332988 Free PMC article.

9

Inflammation-restraining effects of prostaglandin E2 on natural killer-dendritic cell (NK-DC) interaction are imprinted during DC maturation.

Van Elssen CH, Vanderlocht J, Oth T, Senden-Gijsbers BL, Germeraad WT, Bos GM. Van Elssen CH, et al. Blood. 2011 Sep 1;118(9):2473-82. doi: 10.1182/blood-2010-09-307835. Epub 2011 Jun 29. Blood. 2011. PMID: 21715307 Free article.

10

Natural killer cells: the secret weapon in dendritic cell vaccination strategies.

Van Elssen CH, Oth T, Germeraad WT, Bos GM, Vanderlocht J. Van Elssen CH, et al. Clin Cancer Res. 2014 Mar 1;20(5):1095-103. doi: 10.1158/1078-0432.CCR-13-2302. Clin Cancer Res. 2014. PMID: 24590885 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page